Chary-Valckenaere I, Fener P, Jouzeau J Y, Netter P, Payan E, Floquet J, Burnel D, Kessler M, Pourel J, Gaucher A
Department of Rheumatology, URA CNRS 1288, Vandoeuvre-les-Nancy, France.
J Rheumatol. 1994 Aug;21(8):1542-7.
To investigate the articular toxicity of 2 aluminum derivatives, one insoluble (hydroxide) and/or the other soluble (lactate), after a single administration in rabbits and rats.
First, aluminum levels in plasma, urine, synovial tissue, liver and kidney were measured in saline treated rabbits and 1 to 2 days after an articular injection of 75 mg of aluminum compounds into their right knee. The methodology used was argon plasma emission spectrometry. Thereafter, the joint toxicity of aluminum lactate at the same dose regimen was evaluated for 2 days by a qualitative histological examination of synovial tissue and articular surfaces and a colorimetric assay (1,9-DMB) of patellar articular cartilage proteoglycan content. Secondly, the single injection of 50 mg of aluminum derivatives as an inducer of inflammation was studied in the rat subcutaneous air pouch, a model for a synovial-like space. Leukocytes and eicosanoids levels were measured in pouch washout fluids from 1 to 72 h after injection.
After injection into rabbit knee, aluminum lactate largely distributed within the body while hydroxide remained locally. However, aluminum lactate resulted in perivascular edema, sparse infiltration of inflammatory cells in the synovium and a hemorrhagic effusion. Proliferation of the synovial cell layer coexisted with an apparent loss of proteoglycan in superficial zones of tibial and femoral cartilages when patellar proteoglycan content remained unchanged. Aluminum hydroxide did not affect joint structures. In the air pouch experiment, aluminum lactate increased prostaglandin E2 (PGE2) levels from 3 to 10 h after its injection and less intensively leukotriene B4 (LTB4) levels after 6 h, in the absence of leukocytes migration into the cavity. In contrast, aluminum hydroxide increased leukocytes count in pouch-washout fluid from 3 to 24 h after its injection when PGE2 and LTB4 levels were little modified.
Although some differences attributable to dissimilarities in the experimental model used, aluminum compounds, even in a soluble form, may damage joint structures either directly or through stimulating the secretion of eicosanoids by synovial-like cells.
研究两种铝衍生物(一种不溶性的(氢氧化铝)和另一种可溶性的(乳酸铝))单次给药后对家兔和大鼠的关节毒性。
首先,在生理盐水处理的家兔以及右膝关节注射75mg铝化合物后的1至2天,测量血浆、尿液、滑膜组织、肝脏和肾脏中的铝含量。所采用的方法是氩等离子体发射光谱法。此后,通过对滑膜组织和关节表面进行定性组织学检查以及对髌骨关节软骨蛋白聚糖含量进行比色测定(1,9 - DMB),在相同剂量方案下对乳酸铝的关节毒性进行了2天的评估。其次,在大鼠皮下气囊(一种类似滑膜腔的模型)中研究了单次注射50mg铝衍生物作为炎症诱导剂的情况。在注射后1至72小时测量气囊冲洗液中的白细胞和类花生酸水平。
注入家兔膝关节后,乳酸铝在体内广泛分布,而氢氧化铝则留在局部。然而,乳酸铝导致血管周围水肿、滑膜中炎性细胞稀疏浸润以及出血性渗出。当髌骨关节软骨蛋白聚糖含量保持不变时,滑膜细胞层的增殖与胫骨和股骨软骨表层蛋白聚糖的明显丢失同时存在。氢氧化铝未影响关节结构。在气囊实验中,乳酸铝在注射后3至10小时使前列腺素E2(PGE2)水平升高,在6小时后使白三烯B4(LTB4)水平升高程度较轻,且无白细胞迁移到腔内。相比之下,氢氧化铝在注射后3至24小时使气囊冲洗液中的白细胞计数增加,而PGE2和LTB4水平变化不大。
尽管由于所使用的实验模型不同存在一些差异,但铝化合物即使以可溶形式存在,也可能直接或通过刺激类似滑膜细胞分泌类花生酸来损害关节结构。